Meihua International Medical Technologies Co., Ltd. has successfully transferred to the Nasdaq Capital Market and received an extension until December 1, 2025, to comply with the minimum bid price requirement after initially being notified on December 3, 2024. If compliance is not achieved by then, the company risks delisting its shares.